Image
Portfolio

Venture Portfolio - Amyl Therapeutics

AMYL THERAPEUTICS

Key Figures

  • 2020
    Creation Date
  • 2021
    Investment Date
  • Mérieux Participations 1
    Fund Name

Company Presentation

Amyl Therapeutics is a preclinical-stage biotechnology compagny pioneering a breakthrough approach to treating rare and severe peripheral protein misfolding diseases.

By developing novel therapies that recognize and target multiple misfloded proteins, they aim to make a transformative impact on the lives of patients affected by systemic amaloidosis.

Location

98 Rue Del Rodge Cinse - 4102 Seraing, Belgium

Website